Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival.

Pihlgren M, Friedli M, Tougne C, Rochat AF, Lambert PH, Siegrist CA.

J Immunol. 2006 Jan 1;176(1):165-72.

2.

APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.

Belnoue E, Pihlgren M, McGaha TL, Tougne C, Rochat AF, Bossen C, Schneider P, Huard B, Lambert PH, Siegrist CA.

Blood. 2008 Mar 1;111(5):2755-64. doi: 10.1182/blood-2007-09-110858. Epub 2008 Jan 7.

3.

Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life.

Pihlgren M, Schallert N, Tougne C, Bozzotti P, Kovarik J, Fulurija A, Kosco-Vilbois M, Lambert PH, Siegrist CA.

Eur J Immunol. 2001 Mar;31(3):939-46.

4.

Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow.

Minehata K, Takeuchi M, Hirabayashi Y, Inoue T, Donovan PJ, Tanaka M, Miyajima A.

Int J Hematol. 2006 Nov;84(4):319-27.

PMID:
17118758
5.

The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity.

Minges Wols HA, Underhill GH, Kansas GS, Witte PL.

J Immunol. 2002 Oct 15;169(8):4213-21.

6.
7.

VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF.

Schaumann DH, Tuischer J, Ebell W, Manz RA, Lauster R.

Mol Immunol. 2007 Mar;44(7):1606-12. Epub 2006 Oct 25.

PMID:
17067679
8.

Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.

Honczarenko M, Ratajczak MZ, Nicholson-Weller A, Silberstein LE.

J Immunol. 2005 Sep 15;175(6):3698-706.

9.
10.

Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, Muehlinghaus G, Berek C, Hiepe F, Manz R, Radbruch A, Dörner T.

Blood. 2005 Feb 15;105(4):1614-21. Epub 2004 Oct 26.

11.

Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization.

Blink EJ, Light A, Kallies A, Nutt SL, Hodgkin PD, Tarlinton DM.

J Exp Med. 2005 Feb 21;201(4):545-54. Epub 2005 Feb 14.

13.

Primitive hematopoietic cell populations reside in the spleen: Studies in the pig, baboon, and human.

Dor FJ, Ramirez ML, Parmar K, Altman EL, Huang CA, Down JD, Cooper DK.

Exp Hematol. 2006 Nov;34(11):1573-82.

PMID:
17046577
14.
15.

FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.

Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E, Walker EU, Manz RA, Tarlinton DM, Smith KG.

Nat Immunol. 2007 Apr;8(4):419-29. Epub 2007 Feb 18.

PMID:
17322888
16.
17.

Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells.

Pellegrino A, Ria R, Di Pietro G, Cirulli T, Surico G, Pennisi A, Morabito F, Ribatti D, Vacca A.

Br J Haematol. 2005 Apr;129(2):248-56.

PMID:
15813853
18.

Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies.

González-García I, Rodríguez-Bayona B, Mora-López F, Campos-Caro A, Brieva JA.

Blood. 2008 Jan 15;111(2):741-9. Epub 2007 Oct 9.

19.

TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood.

Zhang Q, Guo R, Schwarz EM, Boyce BF, Xing L.

Arthritis Res Ther. 2008;10(2):R37. doi: 10.1186/ar2391. Epub 2008 Mar 27.

20.

Bone marrow microenvironmental changes in aged mice compromise V(D)J recombinase activity and B cell generation.

Labrie JE 3rd, Borghesi L, Gerstein RM.

Semin Immunol. 2005 Oct;17(5):347-55. Review.

PMID:
15963731

Supplemental Content

Support Center